The Protective Effect of HCV Cure on HCC Risk May be over-Estimated in Patients with Advanced Liver Disease

被引：0

作者：

Branch, Andrea D. ^{[1
]}

Lewis, Sara ^{[2
]}

Wyatt, Brooke ^{[3
]}

Doyle, Erin ^{[1
]}

Sung, Julie C. ^{[3
]}

Misra, Suresh ^{[4
]}

Eng, Francis ^{[5
]}

Bosh, Ciara ^{[5
]}

Friedman, Scott L. ^{[6
]}

Dieterich, Douglas T. ^{[3
]}

Aloman, Costica ^{[3
]}

Branch-Elliman, Westyn ^{[7
,8
]}

Perumalswami, Ponni V. ^{[3
]}

机构：

[1] ISMMS, Div Liver Dis, Dept Med, New York, NY USA

[2] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA

[3] ISMMS, New York, NY USA

[4] ISMMS, Dept Med, New York, NY USA

[5] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA

[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[7] VA Boston Healthcare Syst, Dept Med, Sect Infect Dis, Washington, DC USA

[8] Harvard Med Sch, Boston, MA USA

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

919

引用

页码：538A / 539A

页数：2

共 50 条

[1] HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
Semmler, Georg
Meyer, Elias Laurin
Kozbial, Karin
Schwabl, Philipp
Hametner-Schreil, Stefanie
Zanetto, Alberto
Bauer, David
Chromy, David
Simbrunner, Benedikt
Scheiner, Bernhard
Stattermayer, Albert F.
Pinter, Matthias
Schofl, Rainer
Russo, Francesco Paolo
Greenfield, Helena
Schwarz, Michael
Schwarz, Caroline
Gschwantler, Michael
Lopez, Sonia Alonso
Luisa Manzano, Maria
Ahumada, Adriana
Banares, Rafael
Pons, Monica
Rodriguez-Tajes, Sergio
Genesca, Joan
Lens, Sabela
Trauner, Michael
Ferenci, Peter
Reiberger, Thomas
Mandorfer, Mattias
JOURNAL OF HEPATOLOGY, 2022, 76 (04) : 812 - 821
[2] Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Sanduzzi-Zamparelli, Marco
Marino, Zoe
Lens, Sabela
Sapena, Victor
Iserte, Gemma
Pla, Anna
Granel, Nuria
Bartres, Concepcio
Llarch, Neus
Vilana, Ramon
Nunez, Isabel
Darnell, Anna
Belmonte, Ernest
Garcia-Criado, Angeles
Diaz, Alba
Munoz-Martinez, Sergio
Ayuso, Carmen
Bianchi, Luis
Fuster-Anglada, Carla
Rimola, Jordi
Forner, Alejandro
Torres, Ferran
Bruix, Jordi
Forns, Xavier
Reig, Maria
JOURNAL OF HEPATOLOGY, 2022, 76 (04) : 874 - 882
[3] Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease
Semmler, Georg
Binter, Teresa
Kozbial, Karin
Schwabl, Philipp
Hametner-Schreil, Stefanie
Zanetto, Alberto
Gavasso, Sabrina
Chromy, David
Bauer, David J. M.
Simbrunner, Benedikt
Scheiner, Bernhard
Bucsics, Theresa
Staettermayer, Albert F.
Pinter, Matthias
Steindl-Munda, Petra
Schoefl, Rainer
Russo, Francesco Paolo
Simioni, Paolo
Trauner, Michael
Ferenci, Peter
Reiberger, Thomas
Mandorfer, Mattias
HEPATOLOGY, 2021, 73 (04) : 1275 - 1289
[4] TREATMENT OF HCV IN HCC PATIENTS AFTER LIVER TRANSPLANTATION IMPROVES SURVIVAL AND DECREASES RISK OF HCC RECURRENCE
Niyazi, Fadi
Sanghi, Vedha
Abduljawad, Baraa
Asfari, Mohammad Maysara
Lopez, Rocio
Menon, K. V. Narayanan
Romero-Marrero, Carlos
GASTROENTEROLOGY, 2017, 152 (05) : S1103 - S1103
[5] DIABETES MELLITUS INCREASES THE RISK OF LIVER CIRRHOSIS AND HCC IN SAUDI HCV PATIENTS
AlBenmousa, A.
Qadri, M.
Mdani, A.
Bzeizi, K.
JOURNAL OF HEPATOLOGY, 2015, 62 : S599 - S600
[6] Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Semmler, Georg
Alonso Lopez, Sonia
Pons, Monica
Lens, Sabela
Dajti, Elton
Griemsmann, Marie
Zanetto, Alberto
Burghart, Lukas
Hametner-Schreil, Stefanie
Hartl, Lukas
Manzano, Marisa
Rodriguez-Tajes, Sergio
Zanaga, Paola
Schwarz, Michael
Gutierrez, Maria Luisa
Jachs, Mathias
Pocurull, Anna
Polo, Benjamin
Ecker, Dominik
Mateos, Beatriz
Izquierdo, Sonia
Real, Yolanda
Balcar, Lorenz
Carbonell-Asins, Juan Antonio
Gschwantler, Michael
Russo, Francesco Paolo
Azzaroli, Francesco
Maasoumy, Benjamin
Reiberger, Thomas
Forns, Xavier
Genesca, Joan
Banares, Rafael
Mandorfer, Mattias
Agostini, Sofia Maria
Battistella, Sara
Casanova-Cabral, Michelle
Bauer, David Josef Maria
Chromy, David
Cornberg, Markus
Deterding, Katja
Fernandez, Inmaculada
Fernandez-Rodriguez, Conrado
Gea, Francisco
Krawanja, Julia
Mauz, Jim Benjamin
Neumayer, Daniela
Ahumada, Adriana
Riado, Daniel
Rincon, Diego
Schwabl, Philipp
HEPATOLOGY, 2024,
[7] EFFECT OF RITUXIMAB ON ADVANCED LIVER DISEASE IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA
Petrarca, Antonio
Rigacci, Luigi
Arena, Umberto
Vizzutti, Francesco
Giannini, Carlo
Montalto, Paolo
Bosi, Alberto
Colagrande, Stefano
Romagnoli, Paolo
Laffi, Giacomo
Zignego, Anna Linda
HEPATOLOGY, 2008, 48 (04) : 317A - 318A
[8] Validation and refinement of the Baveno VII criteria for risk stratification in compensated advanced chronic liver disease after HCV-cure
Semmler, Georg
Alonso Lopez, Sonia
Pons, Monica
Lens, Sabela
Dajti, Elton
Griemsmann, Marie
Zanetto, Alberto
Burghart, Lukas
Hametner-Schreil, Stephanie
Hartl, Lukas
Ahumada, Adriana
Rodriguez-Tajes, Sergio
Zanaga, Paola
Schwarz, Michael
Uson, Clara
Jachs, Mathias
Pocurull, Anna
Manzano Alonso, Maria Luisa
Ecker, Dominik
Riado, Daniel
Mateos Munoz, Beatriz
Gschwantler, Michael
Paolo Russo, Francesco
Azzaroli, Francesco
Maasoumy, Benjamin
Reiberger, Thomas
Forns, Xavier
Genesca, Joan
Banares, Rafael
Mandorfer, Mattias
JOURNAL OF HEPATOLOGY, 2023, 78 : S299 - S300
[9] SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE
Alves, Rogerio C.
Alves, Daniele E.
Guz, Betty
Viana, Monica V.
Harriz, Michelle C.
Matos, Carla A.
Terrabuio, Deborah
Chagas, Aline
Moutinho, Renata D.
Taddeo, Eliane F.
Duarte, Kelly C.
Oliveira, George P.
Ribeirol, Juliana M.
Kondo, Mario
Gampel, Otavio
Poletti, Paula
HEPATOLOGY, 2010, 52 (04) : 1193A - 1193A
[10] Predictors of advanced liver disease in HCV/HIV coinfected patients.
Stein, DF
Schackman, B
Bengualid, V
Dahdouh, M
Reina, J
Hwang, R
Sianati, R
Munsiff, A
Berger, J
HEPATOLOGY, 2002, 36 (04) : 552A - 552A

← 1 2 3 4 5 →